Maze Therapeutics(MAZE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MAZE Maze Therapeutics

Post-Mkt 04-02 16:37:35 EDT

28.71

-0.34

-1.17%

盘后28.71

+0.000.00%

16:14 EDT

High29.84	Low28.00	Vol780.44K
Open28.28	D1 Closing29.05	Amplitude6.33%
Mkt Cap1.43B	Tradable Cap837.20M	Total Shares49.71M
T/O22.51M	T/O Rate2.68%	Tradable Shares29.16M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MAZE","market":"US","secType":"STK","nameCN":"Maze Therapeutics","latestPrice":28.71,"timestamp":1775160000000,"preClose":29.05,"halted":0,"volume":780436,"hourTrading":{"tag":"盘后","latestPrice":28.71,"preClose":28.71,"latestTime":"16:14 EDT","volume":10618,"amount":304841.654492,"timestamp":1775160852939,"change":0,"changeRate":0,"amplitude":0.000697},"delay":0,"changeRate":-0.011703958691910495,"floatShares":29160400,"shares":49708658,"eps":-2.8431,"marketStatus":"Post-Mkt","change":-0.34,"latestTime":"04-02 16:37:35 EDT","open":28.28,"high":29.84,"low":28,"amount":22507340.6533,"amplitude":0.063339,"askPrice":29.28,"askSize":68,"bidPrice":28.15,"bidSize":71,"shortable":3,"etf":0,"ttmEps":-2.8431,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1775174400000},"marketStatusCode":4,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":29.05,"preHourTrading":{"tag":"盘前","latestPrice":28.3,"preClose":29.05,"latestTime":"09:28 EDT","volume":508,"amount":14332.899452000001,"timestamp":1775136480095,"change":-0.75,"changeRate":-0.025818,"amplitude":0.113955},"postHourTrading":{"tag":"盘后","latestPrice":28.71,"preClose":28.71,"latestTime":"16:14 EDT","volume":10618,"amount":304841.654492,"timestamp":1775160852939,"change":0,"changeRate":0,"amplitude":0.000697},"volumeRatio":0.545036,"impliedVol":0.7012,"impliedVolPercentile":0.4745},"requestUrl":"/m/hq/s/MAZE","defaultTab":"news","newsList":[{"id":"2624682398","title":"Maze SVP Finance Amy Bachrodt disposes Maze Therapeutics shares worth $0.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624682398","media":"Reuters","labels":["shareholding","insiderTrades"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2624682398?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:11","pubTimestamp":1775160684,"startTime":"0","endTime":"0","summary":"Maze Therapeutics SVP, Finance Amy Bachrodt reported sales of 2,500 shares on April 1, 2026.Disposals totaled 2,200 shares at $29.32 per share, weighted average.Additional 300 shares were sold at $30.34 per share, weighted average.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL8sVnMF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maze SVP Finance Amy Bachrodt disposes Maze Therapeutics shares worth $0.1 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624823126","title":"Maze Therapeutics President R&D, CMO Harold Bernstein disposes shares worth $0.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624823126","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624823126?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:12","pubTimestamp":1775160750,"startTime":"0","endTime":"0","summary":"Maze Therapeutics President, R&D and CMO Harold Bernstein sold 15,000 shares on April 1.Sale prices ranged from $29.24 to $31.07 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL4cD845:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624772555","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2624772555","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624772555?lang=en_us&edition=fundamental","pubTime":"2026-04-02 18:00","pubTimestamp":1775124000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Aehr Test Sys                                   3Q      (.07)  4:05 PM. ·Delta Air Lines Inc.                             1Q       .62   6:30 AM. ·Simply Good Fds                                 2Q       .40   7:00 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IE0005OL40V9.USD","LU1509826696.USD","BK4123","PSMT","BK4187","LU0070302665.USD","BK4196","LU0289960550.SGD","BK4149","NEOG","MAZE","BK4202","BK4608","BK4209","SG9999011175.SGD","APLZ","LAKE","IE00B19Z4B17.USD","LU1069347547.HKD","LU0208291251.USD","APOG","BK4107","IE0004445239.USD","BK4082","IE00B775H168.HKD","IE00B66KJ199.SGD","BK4116","BK4212","IE00BJJMRX11.SGD","LU0054578231.USD","BK4023","LU2108987350.USD","BK4096","LU2552382058.USD","BK4086","LU0175139822.USD","IE00BFSS8Q28.SGD","SGXZ23171101.USD","LU0757428866.USD","LU0128525689.USD","NNOX","LU0203347892.USD","LU0354030511.USD","RPM","KRUS","IE00BN29S564.USD","LU1983260115.SGD","WAFD","BK4008","BK4588","LU0731783048.USD","LU2552382215.SGD","LU1599440770.SGD","IE0031619046.USD","BK4585","BK4559","BK4195","LU0353189680.USD","BK4109","BK4533","LU1481011671.HKD","ANGO","BK4152","BK4504","LU0320765489.SGD","BK4211","BK4007","LU1815336091.USD","LU2211817866.USD","SLP","IE00B7SZL793.SGD","LNN","LU1430594728.SGD","BK4500","IE0004445015.USD","SG9999004303.SGD","RGP","BK4568","AYI","LU0310800965.SGD","AEHR","LU2552382132.HKD","BK4198","BK4609","IE00BJJMRY28.SGD","SG9999003800.SGD","IE00B4JS1V06.HKD","IE00BKVL7J92.USD","LEVI","LU1481011911.USD","GBX","PXED","LU2087625088.SGD","STZ","BYRN","BK4108","LU1035773651.USD","LU0772969993.USD","LU0052756011.USD","BK4169","BK4097","LFCR","BK4121","PGR","LU1585245621.USD","BK4204","APLX","LU0742537680.HKD","BB","LU1366192091.USD","IE00B7KXQ091.USD","LU0731783394.SGD","BK4167","IE00BZ1G4Q59.USD","BK4147","BK4155","LU0170899867.USD","LU0203345920.USD","LU1718418525.SGD","SMPL","BK4547","LU0138981039.USD","LU2355687059.USD","APLD","LU1267930227.SGD","IE00BFSS7M15.SGD","LU0354030438.USD","IE00BFMHRM44.USD","DAL","LU1235295455.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624415549","title":"Maze Therapeutics CSBO Atul Dandekar disposes of common shares worth $0.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624415549","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624415549?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:13","pubTimestamp":1775074397,"startTime":"0","endTime":"0","summary":"Maze Therapeutics CSBO Atul Dandekar sold 7,500 shares on March 30, 2026 at USD 10.42.He also sold 6,710 shares at USD 29.26.An additional 790 shares were sold at USD 30.02.Directly owned stake fell to 10,503 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL6Wpgm9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maze Therapeutics CSBO Atul Dandekar disposes of common shares worth $0.2 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624530335","title":"Maze Therapeutics director Neil Kumar files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2624530335","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624530335?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:21","pubTimestamp":1774988463,"startTime":"0","endTime":"0","summary":"Maze Therapeutics director Neil Kumar filed an initial Form 3 on March 27, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL98kVfY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624536287","title":"Maze Therapeutics Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2624536287","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624536287?lang=en_us&edition=fundamental","pubTime":"2026-04-01 00:22","pubTimestamp":1774974120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2026 12:22 ET (16:22 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155589482","title":"Stock Track | Maze Therapeutics Soars 5.65% Intraday on Positive Analyst Ratings and Target Price Increases","url":"https://stock-news.laohu8.com/highlight/detail?id=1155589482","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155589482?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:35","pubTimestamp":1774964131,"startTime":"0","endTime":"0","summary":"Maze Therapeutics' stock surged 5.65% during Tuesday's intraday trading session, reflecting strong investor interest in the biopharmaceutical company.The price movement follows a series of positive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623583660","title":"J.P. Morgan Sticks to Its Buy Rating for Maze Therapeutics, Inc. (MAZE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623583660","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623583660?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:59","pubTimestamp":1774954798,"startTime":"0","endTime":"0","summary":"In a report released today, Anupam Rama from J.P. Morgan maintained a Buy rating on Maze Therapeutics, Inc., with a price target of $58.00. Accordi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-buy-rating-for-maze-therapeutics-inc-maze-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-buy-rating-for-maze-therapeutics-inc-maze-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311309","title":"U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623311309?lang=en_us&edition=fundamental","pubTime":"2026-03-31 15:39","pubTimestamp":1774942790,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, StarbucksMarch 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Dutch Bros","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL4N40J0NP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESAB","MMED","LU0965508806.USD","APH","SBU","SBUX","MKC","MRK","VRDN","CVS","BROS","ANAB","LECO","XYL","SG","FLS","WAB","IE0034390439.USD","MSA","USAR","VRT","PRGS","CMG","MIDD","PHR","ROK","PAYC","TMO","ABT","HAYW","ADP","USAX","TERN","SHAK","PNW","PCTY","EMR","ETR","MAZE","VLTO","FRDU","VRTL","FRDD","CMGG","F","USGG","CAVA","JACK","LU1721427968.SGD","NRG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623337219","title":"Maze Therapeutics Inc : JP Morgan Raises Target Price to $58 From $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2623337219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623337219?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:21","pubTimestamp":1774930879,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J08C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623315199","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2623315199","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623315199?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:00","pubTimestamp":1774864800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.26)  4:05 PM. ·Dave & Buster                                   4Q       .39   4:05 PM. ·NIKE Class B                                     3Q       .29   4:15 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAG","PHR","AEHR","RNXT","PROP","AURA","BEEM","NNOX","PLAY","MKC.V","SGML","FDS","BCAX","INMB","LW","BHST","CRDL","MAZE","MSM","PENG","PVH","AYI","BIRD","PRGS","SGMO","RH","NGEN","CALM","PRPL","BNZI","LNN","NCNO","BITF","DMAC","NEOG","BTBT","PVLA","NKLR","BYND","AIRO","FC","IMNN","MKC","AIRJ","NKE","APOG","ANGO","NMRA","JILL","INV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623366928","title":"Assessing Maze Therapeutics (MAZE) Valuation After Recent Share Price Weakness And Rich Price To Book Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2623366928","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623366928?lang=en_us&edition=fundamental","pubTime":"2026-03-30 07:14","pubTimestamp":1774826075,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE) has drawn attention after recent trading saw the share price close at US$30.38. Returns over the past month and past 3 months have both shown double digit declines.\nSee our latest analysis for Maze Therapeutics.\nThe recent weakness, including a 4.19% one day and 36.75% seven day share price decline, comes after a very large 1 year total shareholder return of 166.02%. This suggests that momentum has cooled even as longer term holders remain well ahead.\nIf Maze's swings...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-maze/maze-therapeutics/news/assessing-maze-therapeutics-maze-valuation-after-recent-shar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-maze/maze-therapeutics/news/assessing-maze-therapeutics-maze-valuation-after-recent-shar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622384780","title":"Maze Therapeutics, Inc. (MAZE) Gets a Buy from LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2622384780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622384780?lang=en_us&edition=fundamental","pubTime":"2026-03-28 22:37","pubTimestamp":1774708672,"startTime":"0","endTime":"0","summary":"In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Maze Therapeutics, Inc., with a price target of $57.00. K...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maze-therapeutics-inc-maze-gets-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maze-therapeutics-inc-maze-gets-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113012684","title":"Stock Track | Maze Therapeutics Soars 5.17% Intraday on Analyst Insights","url":"https://stock-news.laohu8.com/highlight/detail?id=1113012684","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113012684?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:28","pubTimestamp":1774535319,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE) experienced a significant intraday surge of 5.17% during Thursday's trading session, indicating strong investor interest.The upward movement is attributed to recent analyst...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622985050","title":"Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622985050","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622985050?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:41","pubTimestamp":1774528862,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and C...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zai-lab-zlab-maze-therapeutics-inc-maze-and-compass-therapeutics-cmpx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zai-lab-zlab-maze-therapeutics-inc-maze-and-compass-therapeutics-cmpx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","MAZE","BK4137","LU2488822045.USD","BK4585","LU0029874061.USD","HCSG","LU0128526141.USD","XBI","BK4526","CMPX","BK4139","BK4531","BK4581","BK4548","BK4588","ZLAB","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622400500","title":"BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings","url":"https://stock-news.laohu8.com/highlight/detail?id=2622400500","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622400500?lang=en_us&edition=fundamental","pubTime":"2026-03-26 01:47","pubTimestamp":1774460843,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKingsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL6N40D0LO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBHC","ELVN","DKNG","KBH","IMNN","VNO","ARE","SLG","TERN","MPC","BXP","SRPT","DINO","SATL","TXG","LMT","BWXT","GNRC","BZAI","NOV","SIDU","MAZE","RGR","BG","BEAM","DVN","ADMA","JBLU","GPRO","CHWY","CTAS","PAYX","VLO","LBRT","CORT","PSX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622005426","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2622005426","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622005426?lang=en_us&edition=fundamental","pubTime":"2026-03-26 01:35","pubTimestamp":1774460110,"startTime":"0","endTime":"0","summary":"Maze Therapeutics  said Wednesday its experimental oral medication demonstrated a 35.6% average reduction in a key marker of kidney damage during a Phase 2 clinical trial.The stock fell 32% as intraday volume topped 6.26 million shares, compared with the daily average of 488,452.Anavex Life Sciences  withdrew its application for marketing authorization of its experimental drug blarcamesine in the EU as an add-on treatment for early Alzheimer's disease in adults.The company said the decision follows feedback from the European Medicines Agency's Committee for Medicinal Products for Human Use, indicating it would not be in a position to issue a positive opinion.The stock fell 31% as volume topped 9.92 million shares, versus the daily average of 1.38 million.Micron Technology  commenced offers to purchase six series of outstanding senior notes, with maturities ranging from 2031 to 2035.The stock fell 3.9% as volume topped 41.3 million shares, versus the daily average of almost 36.4 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0642271901.SGD","LU0203347892.USD","LU0274383776.USD","LU2360106780.USD","BK4566","LU0157215616.USD","IE00B5949003.HKD","BK4007","LU1852331112.SGD","LU2931357623.SGD","BK4533","BK4512","BK4585","BK4605","GB00BDT5M118.USD","LU0889566641.SGD","LU2054465674.USD","BK4141","LU1316542783.SGD","AVXL","LU0792757196.USD","LU1323610961.USD","LU2250418816.HKD","LU0109392836.USD","LU0081259029.USD","IE0009356076.USD","LU2211815571.USD","LU2089985449.USD","BK4532","IE00B7SZLL34.SGD","LU2286300806.USD","BK4553","LU0203345920.USD","LU0082616367.USD","LU0056508442.USD","LU2458330169.SGD","LU0154236417.USD","LU2458330243.SGD","MUD","LU1366333091.USD","LU1267930813.SGD","BK4139","BK4527","BK4554","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0889565833.HKD","BK4543","LU2048586759.USD","IE0002270589.USD","MULL","LU1803068979.SGD","MAZE","BK4588","LU0127658192.USD","BK4579","LU0719512351.SGD","BK4575"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622407079","title":"Maze Therapeutics share sell-off an ‘overreaction,’ says Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2622407079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622407079?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:36","pubTimestamp":1774452961,"startTime":"0","endTime":"0","summary":"Raymond James reiterates a Strong Buy rating and $56 price target on Maze Therapeutics (MAZE) after the company announced data from the ongoing Pha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-share-sell-off-an-overreaction-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-share-sell-off-an-overreaction-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","IE00BGHQF748.EUR","BK4127","BK4007","IE00B64PRP62.GBP","LU1363072403.SGD","LU1804176565.USD","RJF","MAZE","LU2265009873.SGD","LU0971096721.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622507036","title":"Maze Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2622507036","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622507036?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:17","pubTimestamp":1774451820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2026 11:17 ET (15:17 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622005074","title":"Maze Therapeutics falls -33.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622005074","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622005074?lang=en_us&edition=fundamental","pubTime":"2026-03-25 22:06","pubTimestamp":1774447607,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE) is down -33.2%, or -$16.28 to $32.72. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-falls-33-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-falls-33-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mazetx.com;ir.mazetx.com","stockEarnings":[{"period":"1week","weight":-0.0845},{"period":"1month","weight":-0.3631},{"period":"3month","weight":-0.2988},{"period":"6month","weight":0.0716},{"period":"1year","weight":1.9343},{"period":"ytd","weight":-0.2988}],"compareEarnings":[{"period":"1week","weight":-0.0024},{"period":"1month","weight":-0.0454},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0209},{"period":"1year","weight":0.168},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Maze Therapeutics","nameEN":"Maze Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Maze Therapeutics(MAZE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Maze Therapeutics(MAZE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Maze Therapeutics,MAZE,Maze Therapeutics股票,Maze Therapeutics股票老虎,Maze Therapeutics股票老虎国际,Maze Therapeutics行情,Maze Therapeutics股票行情,Maze Therapeutics股价,Maze Therapeutics股市,Maze Therapeutics股票价格,Maze Therapeutics股票交易,Maze Therapeutics股票购买,Maze Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Maze Therapeutics(MAZE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Maze Therapeutics(MAZE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}